ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 21 filers reported holding ZOSANO PHARMA CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $479,000 | +89.3% | 295,953 | 0.0% | 0.01% | +75.0% |
Q2 2020 | $253,000 | +33.2% | 295,953 | -12.3% | 0.00% | 0.0% |
Q1 2020 | $190,000 | -63.7% | 337,558 | -2.1% | 0.00% | -42.9% |
Q4 2019 | $524,000 | -21.1% | 344,856 | -18.9% | 0.01% | -30.0% |
Q3 2019 | $664,000 | -69.3% | 425,413 | -35.7% | 0.01% | -64.3% |
Q2 2019 | $2,162,000 | – | 661,247 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 81,829 | $390,000 | 0.00% |
DEUTSCHE BANK AG\ | 100 | $0 | 0.00% |